XML 8 R2.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 90,140 $ 33,218
Short-term marketable securities 85,295 150,236
Prepaid expenses and other current assets 7,788 11,850
Total current assets 183,223 195,304
Property and equipment, net 709 881
Operating lease right-of-use assets 2,270 2,838
Restricted cash 606 606
Other assets 542 596
Total assets 187,350 200,225
Current liabilities:    
Accounts payable 11,100 2,424
Accrued expenses 32,865 20,872
Operating lease liabilities, current 1,151 1,060
Total current liabilities 45,116 24,356
Operating lease liabilities 3,196 4,057
Total liabilities 48,312 28,413
Commitments and contingencies (See Note 8)
Stockholders’ equity:    
Preferred stock; $0.001 par value per share; 5,000,000 shares authorized as of September 30, 2025 and December 31, 2024; no shares issued and outstanding as of September 30, 2025 and December 31, 2024
Common stock, $0.001 par value per share; 115,000,000 shares authorized as of September 30, 2025 and December 31, 2024; 85,590,392 and 63,815,065 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively 86 64
Additional paid-in capital 511,219 440,758
Accumulated deficit (372,333) (269,158)
Accumulated other comprehensive gain 66 148
Total stockholders’ equity 139,038 171,812
Total liabilities and stockholders’ equity $ 187,350 $ 200,225